File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S1521-6934(03)00068-3
- Scopus: eid_2-s2.0-0141830265
- PMID: 12972013
- WOS: WOS:000185671700007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Prostaglandins for induction of second-trimester termination and intrauterine death
Title | Prostaglandins for induction of second-trimester termination and intrauterine death |
---|---|
Authors | |
Keywords | Intrauterine death Prostaglandin Second-trimester abortion |
Issue Date | 2003 |
Publisher | Bailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpobgyn |
Citation | Best Practice And Research: Clinical Obstetrics And Gynaecology, 2003, v. 17 n. 5, p. 765-775 How to Cite? |
Abstract | The introduction of synthetic prostaglandin has revolutionized the treatment protocol for induction of second-trimester abortion and intrauterine death. Gemeprost is the only licensed synthetic prostaglandin analogue for second-trimester abortion in the United Kingdom. However, it is expensive and needs to be stored in a refrigerator. Misoprostol is marketed for use in the prevention and treatment of peptic ulcer. It is inexpensive and can be stored at room temperature. It has been widely used for induction of second-trimester abortion and intrauterine death. Misoprostol, 400 μg given vaginally every 3 hours, is probably the optimal regimen for second-trimester abortion. The combination of misoprostol and mifepristone significantly reduced the induction-to-abortion interval when compared with the misoprostol-only regimen. In addition, misoprostol can also be used as a cervical priming agent prior to dilatation and evacuation in second-trimester abortion. |
Persistent Identifier | http://hdl.handle.net/10722/87164 |
ISSN | 2023 Impact Factor: 3.9 2023 SCImago Journal Rankings: 1.532 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ngai, SW | en_HK |
dc.contributor.author | Tang, OS | en_HK |
dc.contributor.author | Ho, PC | en_HK |
dc.date.accessioned | 2010-09-06T09:26:09Z | - |
dc.date.available | 2010-09-06T09:26:09Z | - |
dc.date.issued | 2003 | en_HK |
dc.identifier.citation | Best Practice And Research: Clinical Obstetrics And Gynaecology, 2003, v. 17 n. 5, p. 765-775 | en_HK |
dc.identifier.issn | 1521-6934 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/87164 | - |
dc.description.abstract | The introduction of synthetic prostaglandin has revolutionized the treatment protocol for induction of second-trimester abortion and intrauterine death. Gemeprost is the only licensed synthetic prostaglandin analogue for second-trimester abortion in the United Kingdom. However, it is expensive and needs to be stored in a refrigerator. Misoprostol is marketed for use in the prevention and treatment of peptic ulcer. It is inexpensive and can be stored at room temperature. It has been widely used for induction of second-trimester abortion and intrauterine death. Misoprostol, 400 μg given vaginally every 3 hours, is probably the optimal regimen for second-trimester abortion. The combination of misoprostol and mifepristone significantly reduced the induction-to-abortion interval when compared with the misoprostol-only regimen. In addition, misoprostol can also be used as a cervical priming agent prior to dilatation and evacuation in second-trimester abortion. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Bailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpobgyn | en_HK |
dc.relation.ispartof | Best Practice and Research: Clinical Obstetrics and Gynaecology | en_HK |
dc.subject | Intrauterine death | en_HK |
dc.subject | Prostaglandin | en_HK |
dc.subject | Second-trimester abortion | en_HK |
dc.title | Prostaglandins for induction of second-trimester termination and intrauterine death | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1521-6934&volume=17&issue=5&spage=765&epage=775&date=2003&atitle=Prostaglandins+for+induction+of+second-trimester+termination+and+intrauterine+death | en_HK |
dc.identifier.email | Ho, PC:pcho@hku.hk | en_HK |
dc.identifier.authority | Ho, PC=rp00325 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/S1521-6934(03)00068-3 | en_HK |
dc.identifier.pmid | 12972013 | - |
dc.identifier.scopus | eid_2-s2.0-0141830265 | en_HK |
dc.identifier.hkuros | 87477 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0141830265&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 17 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | 765 | en_HK |
dc.identifier.epage | 775 | en_HK |
dc.identifier.isi | WOS:000185671700007 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Ngai, SW=7006074214 | en_HK |
dc.identifier.scopusauthorid | Tang, OS=7006723402 | en_HK |
dc.identifier.scopusauthorid | Ho, PC=7402211440 | en_HK |
dc.identifier.issnl | 1521-6934 | - |